PM

Pallavi Mehra

Active Director Director DIN 08117638
DIN 08117638 First appointment Apr 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Pallavi Mehra

Data last updated:

Pallavi Mehra is a Director at Sarita Diagnostic Centre Private Limited (since 2018). The company operates in Healthcare. Sarita Diagnostic Centre Private Limited reported revenue of ₹5.67 Cr (FY 2024).

DIN 08117638
Primary Designation Director
Industry Healthcare
First Appointment 23 Apr 2018
Oldest Company Age 8 yrs
Largest company Sarita Diagnostic Centre Private Limited · ₹5.67 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Apr 20182018₹5.67 Cr (FY 2024)Active

Board colleagues of Pallavi Mehra

Directorship timeline

Open interactive timeline →
Sarita Diagnostic Centre Private Limited
Premium access

Shareholding and investment profile for Pallavi Mehra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pallavi Mehra

Pallavi Mehra currently holds 1 directorship: Sarita Diagnostic Centre Private Limited (Director, since 23 Apr 2018, revenue ₹5.67 Cr (FY 2024)).

Pallavi Mehra was first appointed on 23 Apr 2018 as Director at Sarita Diagnostic Centre Private Limited.

The current boards of Pallavi Mehra's companies include Raj Narayan Mehra (Sarita Diagnostic Centre Private Limited), Rakesh Mehra (Sarita Diagnostic Centre Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available